Office of the Dean

A Message from Dean Augustine M.K. Choi

I am thrilled to lead Weill Cornell Medicine as its 15th dean—especially now, at a time of exciting growth and possibility.

Weill Cornell Medicine’s top-ranked physicians, scientists, and students have been engaging in world-class clinical care, cutting-edge research, and innovative medical education for well over a century. The institution has evolved in response to contemporary challenges and opportunities, while advancing steadily in its mission to improve human health.

Today Weill Cornell Medicine is poised to build on this rich legacy and become a triple threat in academic medicine—renowned for its commitment to “Care. Discover. Teach.”

Increasing numbers of patients are benefitting from the exceptional care provided by Weill Cornell Medicine physicians, as we work with hospital partner NewYork-Presbyterian to expand clinical services throughout New York City. Our biomedical investigators are propelling basic, translational, and clinical research forward, seeking to understand and intervene in conditions across the spectrum of disease. With a new medical curriculum and robust educational collaborations across Cornell’s campuses, Weill Cornell Medicine is also training the next generation of physicians and scientists.

Weill Cornell Medicine is uniquely positioned to accelerate its efforts in medicine and biomedical science and to make a significant, positive impact on the health of individuals both in New York and around the world. And with the dedication of our faculty, trainees, students, and staff, together we will make this vision a reality.

Augustine M.K. Choi, M.D.

Stephen and Suzanne Weiss Dean
Weill Cornell Medicine


Dr. Augustine M.K. Choi


Dean's Letters

Weill Cornell Medicine's Commitment to Research

(August 02, 2017)
Dear Weill Cornell Medicine Community, As Congressional committees develop next year's budget, one issue looms especially large for scientific investigators around the country. The Trump administration's FY 2018 budget proposal includes a $7.2 billion cut to the National Institutes of Health plus a 10% cap on reimbursement of facilities and administrative (F&A) costs on NIH grants. F&A expenditures, which are also known as indirect costs, refer to expenses related to research infrastructure and operations, including utilities, high-speed data processing, waste...
[READ MORE]

Dean's Letters Archives